Life Science Angels
Non-Profit
Active
Sunnyvale, United States
83
3M
59
4.15
3
0.28
7
- Stages of investment
- Areas of investment
Summary
Life Science Angels is the famous VC, which was founded in 2004. The main department of described VC is located in the Sunnyvale. The fund was located in North America if to be more exact in United States.
The fund is constantly included in 2-6 investment rounds annually. The common things for fund are deals in the range of 5 - 10 millions dollars. When the investment is from Life Science Angels the average startup value is 1-5 millions dollars. The real fund results show that this VC is 4 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Life Science Angels performs on 13 percentage points less the average number of lead investments. The top amount of exits for fund were in 2018.
The fund was created by Allan May. Besides them, we counted 18 critical employees of this fund in our database.
The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Medical Device, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight Vaxart, Verdezyne, OncoHealth. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Life Science Angels, startups are often financed by Tech Coast Angels, Sand Hill Angels, Kentucky Science and Technology Corporation (KSTC). The meaningful sponsors for the fund in investment in the same round are Tech Coast Angels, Sand Hill Angels, The Angels' Forum. In the next rounds fund is usually obtained by Tech Coast Angels, Sand Hill Angels, OVP Venture Partners.
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 83
- Lead investments
- 3
- Exits
- 7
- Rounds per year
- 4.15
- Follow on index
- 0.28
- Investments by industry
- Biotechnology (58)
- Health Care (48)
- Medical Device (18)
- Medical (17)
- Life Science (12) Show 31 more
- Investments by region
-
- United States (79)
- The Netherlands (1)
- Israel (1)
- Peak activity year
- 2021
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 7M
- Group Appearance index
- 0.60
- Avg. company exit year
- 8
- Avg. multiplicator
- 3.98
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Allyx Therapeutics | 01 Jun 2021 | Biotechnology, Health Care, Medical, Life Science | Early Stage Venture | 7M | United States, New York, New Haven |
| Confirm.io (Acquired by Facebook) | 01 Apr 2017 | Internet, Software, Computer, Identity Management | Seed | United States, Massachusetts, Boston | |
| NSpine | 11 Oct 2005 | Health Care, Education, Medical Device | Early Stage Venture | 415K | United States, California, San Diego |
| Risika | 01 Jun 2020 | Software, FinTech, Information Technology, Information Services, SaaS, Big Data, Business Intelligence, Credit, Database, Risk Management | Seed | 475K | Hovedstaden, Copenhagen, Denmark |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.